Revolutionizing the Medical Industry: Shockwave Medical’s Groundbreaking ESG Report Unveiled!
SANTA CLARA, Calif., Nov. 16, 2022 (GLOBE NEWSWIRE) — Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat severely calcified cardiovascular disease, today announced the publication of its inaugural Environmental, Social, and Governance (ESG) report highlighting the company’s corporate responsibility and sustainability initiatives. About the ESG Report Shockwave…